<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962076</url>
  </required_header>
  <id_info>
    <org_study_id>F141013002</org_study_id>
    <nct_id>NCT02962076</nct_id>
  </id_info>
  <brief_title>Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia</brief_title>
  <official_title>Cardiac Positron Emission Tomography for Detection of Cardiac Sympathetic Dysinnervation to Guide Ablation of Ventricular Tachycardia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mercy Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Biosense Webster, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mercy Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Imaging is to be performed prior to procedure using positron emission tomography/ computed&#xD;
      tomography (PET/CT), after a special dye is injected. The scans are going to be merged with&#xD;
      other cardiac scans when doing the ablation procedure to correlate anatomy with physiology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between PET data and electroanatomic data</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>[C-11] Meta-hydroxyephedrine radioactive tracer (MHED)</intervention_name>
    <description>this tracer detects the distribution of sympathetic nerve fibers in the left ventricle</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical indication for ventricular tachycardia (VT) ablation (at least one clinical&#xD;
             episode of sustained VT) despite antiarrhythmic drug therapy, or if the patient does&#xD;
             not wish to be on one&#xD;
&#xD;
          -  Ischemic or nonischemic cardiomyopathy&#xD;
&#xD;
          -  Sustained monomorphic VT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Right ventricular VT&#xD;
&#xD;
          -  Polymorphic VT or ventricular fibrillation (VF) being the sole detected clinical&#xD;
             arrhythmia&#xD;
&#xD;
          -  Patient is unable to sign informed consent&#xD;
&#xD;
          -  Recent myocardial infarction less than 30 days&#xD;
&#xD;
          -  Recent ablation for ventricular tachycardia less than 30 days&#xD;
&#xD;
          -  Patient is unwilling or unable to cooperate with the study&#xD;
&#xD;
          -  Prosthetic mitral or aortic valve&#xD;
&#xD;
          -  General contraindications to VT ablation, e.g., major contraindication to&#xD;
             anticoagulation therapy, known presence of left ventricular thrombus, reversible&#xD;
             causes of VT or VF&#xD;
&#xD;
          -  General contraindications to PET imaging, e.g., pregnancy or lactation&#xD;
&#xD;
          -  General contraindication to magnetic resonance imaging or to the administration of&#xD;
             gadolinium.&#xD;
&#xD;
          -  Contraindication to the placement of hemodynamic support devices, i.e. the presence of&#xD;
             mechanical valves or lack of adequate vascular access&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Khaled Awad, MD</last_name>
    <phone>314-251-3920</phone>
    <email>Khaled.Awad@mercy.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mercy Hospital St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaled Awad, MD</last_name>
      <phone>314-251-3920</phone>
      <email>Khaled.Awad@mercy.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mercy Research</investigator_affiliation>
    <investigator_full_name>Khaled Awad, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

